pdCSM-GPCR
pdCSM-GPCR predicts potent small-molecule ligands for G protein-coupled receptors (GPCRs) using graph-based signatures to support identification and prioritization of GPCR ligands in drug discovery.
Key Features:
- Graph-Based Signatures: Uses graph-based signatures to model ligand–GPCR interactions.
- Comprehensive Predictive Models: Built from curated bioactivity data (IC50, EC50, Ki, and Kd) for 36 GPCR targets across classes A, B, C, and F.
- High Performance: Validated by stratified 10-fold cross-validation and blind tests achieving Pearson correlations up to 0.89 and outperforming previous methods.
- Feature Identification: Identified structural features associated with potent GPCR ligands, including bicyclic rings and increased aromaticity.
Scientific Applications:
- Drug Discovery and Development: Screens and prioritizes compound libraries for potential GPCR ligands to guide experimental validation.
- Research and Analysis: Provides insights into structural determinants of ligand potency to support studies of GPCR–ligand interactions.
Methodology:
Curated bioactivity data (IC50, EC50, Ki, and Kd) for 36 GPCR targets across classes A, B, C, and F and used graph-based signatures to construct predictive models evaluated by stratified 10-fold cross-validation and blind tests.
Topics
Collections
Details
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 5/19/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Velloso JPL, Ascher DB, Pires DEV. pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures. Bioinformatics Advances. 2021;1(1). doi:10.1093/bioadv/vbab031. PMID:34901870. PMCID:PMC8651072.
PMID: 34901870
PMCID: PMC8651072
Funding: - The Medical Research Council: MR/M026302/1
- Wellcome Trust: 093167/Z/10/Z
- Investigator Grant from the National Health and Medical Research Council (NHMRC) of Australia: GNT1174405
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil: 001